Dr. Geordie Rose founded D-Wave, the world's first quantum computing company, and Kindred, the world's first robotics company.
He cooperated with Google, NASA, Lockheed Martin, and US government agencies. Currently, he is trying to solve the AGI problem at Sanctuary, the leading company in the AI sector.
Dr. Charles Cantor is co-founder, and CSO at SEQUENOM, the leading provider of noninvasive parental testing.
Dr. Charles has focused his attention on developing rational and cost-effective approaches to preventive and personalized medicine.
He held academic and leadership positions at Columbia and several other distinguished American universities.
Mr. Dan Scholefield is a co-founder of Diagnomics and is currently taking on the role as CFO and Chairman of the Board.
He serves as a trustee, managing several private family office operations with a tenure that spans over 20 years.
He is also a principal at Three Layer Capital. He brings an experience level and successful investment track record that includes leading due diligence efforts, closing deals and managing investment ventures.
Dr. Stefan Gruenwald the President of Diagnomics.
His career in life science spans more than two decades and he holds three patents, based on technologies developed at PharMingen.
He is also an initiator of popular Science Newsletter with over 300,000 reads. He has broad scientific knowledge in many disciplines, including Biotechnology and Nanotechnology.
Dr. Carlotta Glackin is an Associate Professor and member of the Women's Cancers and Molecular Cellular Biology of Cancer (MCBC) programs at the City of Hope Comprehensive Cancer Center (COHCCC).
Her research has focused primarily on the functional role of elevated TWIST expression in cancer cells.
Mr. Suresh Chukkapalli is the founder of Phoenix Group.
He is a leading professional in the infrastructure industry and has vast experience in the fields of real estate, power, and mines.
In 2017, he has been appointed as Honorary Consul General in Hyderabad by the Republic of Korea, with consular jurisdiction over the state of Telangana
Dr. Min Seob Lee, a global leader in genome research, diagnostic and customized medicine, has a long history of research in the life sciences industry, including biotech companies and diagnostic medical companies.
In particular, he is recognized for his expertise in the fields of genomics, pharmacogenomics, bioinformatics, and diagnostic development.
Mr. Sang Cheol Shin is the co-CEO of the EDGC. After graduating from Yonsei University, he joined Samsung Securities and has been involved with the wide range of business.
Mr. Shin's working experience in investment banking involves interaction with hundreds of companies, and he focused on IPO, M&A, privatization of the public corporation, and capital raises.
He has an excellent understanding for various issues and solutions for corporations at various stages of their corporate life cycle.
Mr. Ha succeeded in developing the Dynamic Security Module for the first time in the world and has commercialized it in various financial and government organizations. He established Joint Venture with SBI Holdings, Japan's largest financial group, and is rapidly expanding Dynamic Security Module worldwide.
Michael O'Reilly's Genomics Personalized Health (GPH) facilitates access to the world's most advanced Whole Genome Sequencing service performed at CLIA certified and CAP accredited laboratories located within the United States.
GPH empowers individuals with their genomic data as the baseline for preventative wellness and lifestyle applications informed by science.